A1MQ
5-Amino-1MQ
Not a peptide. A small-molecule quinolinium salt, permanently positively charged at the ring nitrogen. It is described in the literature as an inhibitor of nicotinamide N-methyltransferase, an enzyme rather than a receptor.
No registered human study names 5-Amino-1MQ as an intervention. ClinicalTrials.gov holds no trial of it, so there is no trial evidence to read — a fact about the public record rather than proof the compound does nothing. No FDA-approved product contains 5-Amino-1MQ. No paper naming 5-Amino-1MQ was published in the last ten years.
Collected 2026-08-02 from ClinicalTrials.gov and Drugs@FDA. Counts include only trials whose registered intervention names 5-Amino-1MQ; the registry search is fuzzy, so every match is re-checked. None of this says whether 5-Amino-1MQ works or is safe.
FDA status
Research only
Human studies
0
Furthest phase
—
Papers, 10 yr
0
Readership
—
Tracking since 2026-07-29 · About this data
What has actually been tested in humans
No registered human study
0
Registered human studies
None
No FDA-approved product contains it
No study of 5-Amino-1MQ in humans is registered on ClinicalTrials.gov. That is a fact about the public record, not a statement that the compound does nothing — but it does mean there is no trial evidence to read, and anyone telling you otherwise should be asked for the registration number. The grade is mechanical: it is computed from the registry and the FDA record alone, and it grades how much is known, never whether a compound is good or safe. Collected 2026-08-02 from ClinicalTrials.gov and Drugs@FDA. Check the query.
Is anyone studying 5-Amino-1MQ?
No paper naming “5-amino-1MQ” in its title or abstract was published between 2017 and 2026, and no registered trial started in that window. That is a fact about the scientific record, not proof the compound does nothing — but it does mean there is no recent literature to read.
Sources: PubMed and ClinicalTrials.gov · collected 2026-08-02 · check the query.
About 5-Amino-1MQ
Not a peptide. A small-molecule quinolinium salt, permanently positively charged at the ring nitrogen. It is described in the literature as an inhibitor of nicotinamide N-methyltransferase, an enzyme rather than a receptor.
Structure and mechanism only. Nothing above describes what this compound is for, and no dose appears anywhere on this page.
Reading on this compound
All articles →PepRack articles that reference this compound. This is not a news feed — we syndicate nothing and publish no datelines.
Vendor listings are not affiliate links and PepRack earns nothing from them. A listing records a price we observed on a date. It is not a recommendation of a product, dose, or treatment, and PepRack does not verify what any vendor ships.